Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
10 2020
Historique:
received: 19 04 2020
accepted: 12 05 2020
pubmed: 2 6 2020
medline: 24 9 2020
entrez: 2 6 2020
Statut: ppublish

Résumé

The current coronavirus disease 2019 (COVID-19) pandemic is a challenge for physicians in triaging patients in emergency rooms. We found a potentially dangerous overlap of classical urinary symptoms and the as yet not fully described symptoms of COVID-19. After a patient was primarily triaged as a urosepsis case and then subsequently diagnosed with COVID-19, we focused on an increase in urinary frequency as a symptom of COVID-19 and identified this in seven males out of 57 patients currently being treated in our COVID-19 wards. In the absence of any other causes, urinary frequency may be secondary to viral cystitis due to underlying COVID-19 disease. We propose consideration of urinary frequency as an anamnestic tool in patients with infective symptoms to increase awareness among urologists during the current COVID-19 pandemic to prevent fatal implications of misinterpreting urological symptoms.

Identifiants

pubmed: 32475747
pii: S0302-2838(20)30353-5
doi: 10.1016/j.eururo.2020.05.013
pmc: PMC7236674
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

624-628

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Références

JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
N Engl J Med. 2020 May 7;382(19):1858-1859
pubmed: 32251568
Eur Urol. 2020 Jul;78(1):e40-e41
pubmed: 32345522
Front Microbiol. 2019 Dec 03;10:2752
pubmed: 31849894
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Virology. 2007 Oct 25;367(2):367-74
pubmed: 17631932
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013

Auteurs

Jan-Niclas Mumm (JN)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany. Electronic address: janniclas.mumm@med.uni-muenchen.de.

Andreas Osterman (A)

National Reference Center for Retroviruses, Max von Pettenkofer Institute and Gene Center, Faculty of Medicine, LMU München, Munich, Germany; German Center for Infection Research, Munich Partner Site, Munich, Germany.

Michael Ruzicka (M)

Medizinische Klinik III, Klinikum der Universität München, Munich, Germany.

Clemens Stihl (C)

Klink für Hals-Nasen-Ohren-Heilkunde, Klinikum der Universität München, Munich, Germany.

Theresa Vilsmaier (T)

Klink für Frauenheilkunde, Klinikum der Universität München, Munich, Germany.

Dieter Munker (D)

Medizinische Klinik V, Klinikum der Universität München, Munich, Germany.

Elham Khatamzas (E)

Medizinische Klinik III, Klinikum der Universität München, Munich, Germany.

Clemens Giessen-Jung (C)

Medizinische Klinik III, Klinikum der Universität München, Munich, Germany.

Christian Stief (C)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Michael Staehler (M)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Severin Rodler (S)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH